Craft

Chromocell

Stock Price

$0.6

2024-10-29

Market Capitalization

$3.7 M

2024-10-29

Revenue

$16.8 M

FY, 2025

Chromocell Summary

Company Summary

Overview
Chromocell Therapeutics is a company focused on the discovery and development of therapeutics and flavors through the use of its Chromovert technology. The company focuses on projects that require multi-gene cell lines or large panels of related receptors.
Type
Public
Status
Active
Founded
2002
HQ
Freehold, NJ, US | view all locations
Website
https://www.chromocell.com/
Cybersecurity rating
Sectors

Key People

  • Francis Knuettel, Interim Chief Executive Officer and Chief Financial Officer, Treasurer and Secretary

    LocationsView all

    1 location detected

    • Freehold, NJ HQ

      United States

      4400 US-9 #1000

    Chromocell Financials

    Summary Financials

    Revenue (Q1, 2026)
    $10.9M
    Gross profit (Q1, 2026)
    $9.2M
    Net income (Q1, 2026)
    ($10.2M)
    Cash (Q1, 2026)
    $32.0M
    EBIT (Q1, 2026)
    ($13.1M)
    Enterprise value
    ($1.7M)

    Footer menu